Christopher Ogden

Chief Financial Officer

Chief Financial Officer at CytomX Therapeutics, Inc., filing insider transactions between 2026-03-17 and 2026-06-15.

Total Purchases

—

0 transactions

Total Sales

$129K

2 transactions

Companies Traded

2 total filings

Active Since

2026-03-17

Last: 2026-06-15

Companies

CytomX Therapeutics, Inc.

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-06-15	CTMX	Sale	1,624	$3.05	$5K	295.3K	SEC ↗
2026-03-17	CTMX	Sale	19.3K	$6.42	$124K	296.9K	SEC ↗